{
  "id": 6261751,
  "title": "Vaxcyte's CEO Parted With Shares for Taxes. Here's What Long-Term Investors Should Know About the Firm",
  "url": "https://urgent.news/2026/09/08/vaxcytes-ceo-parted-with-shares-for-taxes-heres-what-long-term",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T09:24:37.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/filings/2026/09/08/vaxcyte-s-ceo-parted-with-shares-weeks-before-a-phase-3-readout-here-s-what-long-term-investors-should-know/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Grant Pickering, CEO of Vaxcyte Inc. (NASDAQ:PCVX), recently sold 6,289 shares of the company's common stock in a non-discretionary transaction, according to a recent SEC Form 4 filing. The weighted average sale price for the shares was $61.20, while the post-transaction value based on the September 2 market close was $61.58.\n\nVaxcyte Inc. is a San Carlos-based clinical-stage biotechnology company with 507 employees that specializes in developing next-generation protein-based vaccines. The company's innovative approach utilizes advanced conjugate vaccine technology to create multivalent formulations with superior immunogenicity and a broader range of pathogen coverage compared to existing therapeutic options. Vaxcyte's market capitalization stands at $9.0 billion, with a one-year share price appreciation of 95.12%, indicating investor confidence in the company's clinical pipeline and the significant market opportunities within the global vaccine sector.",
  "summary": "The stock has surged 95% over the past year, and the CEO retains about 447,000 direct shares plus indirect holdings.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Vaxcyte's CEO Parted With Shares for Taxes. Here's What Long-Term Investors Should Know About the Firm",
        "url": "https://urgent.news/2026/09/08/vaxcytes-ceo-parted-with-shares-for-taxes-heres-what-long-term-6270749",
        "published": "2026-09-08T09:44:37.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}